As of May 27
| 0.00 / 0.00%|
The 8 analysts offering 12-month price forecasts for Astellas Pharma Inc have a median target of 17.71, with a high estimate of 18.78 and a low estimate of 14.04. The median estimate represents a +33.16% increase from the last price of 13.30.
The current consensus among 8 polled investment analysts is to Buy stock in Astellas Pharma Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.